Literature DB >> 22647693

Regulation of virus neutralization and the persistent fraction by TRIM21.

W A McEwan1, F Hauler, C R Williams, S R Bidgood, D L Mallery, R A Crowther, L C James.   

Abstract

Despite a central role in immunity, antibody neutralization of virus infection is poorly understood. Here we show how the neutralization and persistence of adenovirus type 5, a prevalent nonenveloped human virus, are dependent upon the intracellular antibody receptor TRIM21. Cells with insufficient amounts of TRIM21 are readily infected, even at saturating concentrations of neutralizing antibody. Conversely, high TRIM21 expression levels decrease the persistent fraction of the infecting virus and allows neutralization by as few as 1.6 antibody molecules per virus. The direct interaction between TRIM21 and neutralizing antibody is essential, as single-point mutations within the TRIM21-binding site in the Fc region of a potently neutralizing antibody impair neutralization. However, infection at high multiplicity can saturate TRIM21 and overcome neutralization. These results provide insight into the mechanism and importance of a newly discovered, effector-driven process of antibody neutralization of nonenveloped viruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647693      PMCID: PMC3421726          DOI: 10.1128/JVI.00728-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.

Authors:  C I Toogood; J Crompton; R T Hay
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

2.  A hypothesis accounting for the effect of the host cell on neutralization-resistant virus.

Authors:  L Kjellén
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

3.  Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion.

Authors:  K Wetz; P Willingmann; H Zeichhardt; K O Habermehl
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 4.  Mechanisms of neutralization of animal viruses.

Authors:  N J Dimmock
Journal:  J Gen Virol       Date:  1984-06       Impact factor: 3.891

5.  Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.

Authors:  J Icenogle; H Shiwen; G Duke; S Gilbert; R Rueckert; J Anderegg
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

6.  Quantitative relationships between an influenza virus and neutralizing antibody.

Authors:  H P Taylor; S J Armstrong; N J Dimmock
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

7.  Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera.

Authors:  C E Wohlfart; U K Svensson; E Everitt
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

8.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

Authors:  C Wohlfart
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

9.  Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection.

Authors:  M P Langford; A L Villarreal; G J Stanton
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

Authors:  E A Emini; W A Schleif; J H Nunberg; A J Conley; Y Eda; S Tokiyoshi; S D Putney; S Matsushita; K E Cobb; C M Jett
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

View more
  50 in total

Review 1.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

2.  Collusion between neutralizing antibodies and other immune factions in the destruction of adenoviral vectors.

Authors:  P J Klasse
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

3.  Directed evolution of mutator adenoviruses resistant to antibody neutralization.

Authors:  Nicolle D Myers; Ksenia V Skorohodova; Anshu P Gounder; Jason G Smith
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

4.  More than one way to TRIM a capsid.

Authors:  Jeremy Luban
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-13       Impact factor: 11.205

Review 5.  Coordinated Neutralization and Immune Activation by the Cytosolic Antibody Receptor TRIM21.

Authors:  Adam J Fletcher; Leo C James
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 6.  A perspective on the structure and receptor binding properties of immunoglobulin G Fc.

Authors:  Quinlin M Hanson; Adam W Barb
Journal:  Biochemistry       Date:  2015-05-07       Impact factor: 3.162

7.  Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.

Authors:  P J Klasse
Journal:  Adv Biol       Date:  2014-09-09

8.  TRIM21 Promotes Innate Immune Response to RNA Viral Infection through Lys27-Linked Polyubiquitination of MAVS.

Authors:  Binbin Xue; Huiyi Li; Mengmeng Guo; Jingjing Wang; Yan Xu; Xuan Zou; Rilin Deng; Guangdi Li; Haizhen Zhu
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

9.  Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus.

Authors:  Joshua W Wang; Wai Hong Wu; Tsui-Chin Huang; Margaret Wong; Kihyuck Kwak; Keiko Ozato; Chien-Fu Hung; Richard B S Roden
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

10.  Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation.

Authors:  William A McEwan; Benjamin Falcon; Marina Vaysburd; Dean Clift; Adrian L Oblak; Bernardino Ghetti; Michel Goedert; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.